Literature DB >> 22752915

Effect of Salmonella treatment on an implanted tumor (CT26) in a mouse model.

Misun Yun1, SangO Pan, Sheng-Nan Jiang, Vu Hong Nguyen, Seung-Hwan Park, Che-Hun Jung, Hyung-Seok Kim, Jung-Joon Min, Hyon E Choy, Yeongjin Hong.   

Abstract

The use of bacteria has contributed to recent advances in targeted cancer therapy especially for its tumor-specific accumulation and proliferation. In this study, we investigated the molecular events following bacterial therapy using an attenuated Salmonella Typhimurium defective in ppGpp synthesis (ΔppGpp), by analyzing those proteins differentially expressed in tumor tissues from treated and untreated mice. CT26 murine colon cancer cells were implanted in BALB/c mice and allowed to form tumors. The tumor-bearing mice were treated with the attenuated Salmonella Typhimurium. Tumor tissues were analyzed by 2D-PAGE. Fourteen differentially expressed proteins were identified by mass spectrometry. The analysis revealed that cytoskeletal components, including vimentin, drebrin-like protein, and tropomyosin-alpha 3, were decreased while serum proteins related to heme or iron metabolism, including transferrin, hemopexin, and haptoglobin were increased. Subsequent studies revealed that the decrease in cytoskeletal components occurred at the transcriptional level and that the increase in heme and iron metabolism proteins occurred in liver. Most interestingly, the same pattern of increased expression of transferrin, hemopexin, and haptoglobin was observed following radiotherapy at the dosage of 14 Gy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752915     DOI: 10.1007/s12275-012-2090-9

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  37 in total

1.  ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1.

Authors:  Miryoung Song; Hyun-Ju Kim; Eun Young Kim; Minsang Shin; Hyun Chul Lee; Yeongjin Hong; Joon Haeng Rhee; Hyunjin Yoon; Sangryeol Ryu; Sangyong Lim; Hyon E Choy
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

2.  Assay of proteins in the presence of interfering materials.

Authors:  A Bensadoun; D Weinstein
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

3.  Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation.

Authors:  Douglas H Thamm; Ilene D Kurzman; Ivan King; Zujin Li; Mario Sznol; Richard R Dubielzig; David M Vail; E Gregory MacEwen
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

4.  Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.

Authors:  Ming Zhao; Meng Yang; Huaiyu Ma; Xiaoming Li; Xiuying Tan; Shukuan Li; Zhijian Yang; Robert M Hoffman
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

Review 5.  DNA repair targeting and radiotherapy: a focus on the therapeutic ratio.

Authors:  John Thoms; Robert G Bristow
Journal:  Semin Radiat Oncol       Date:  2010-10       Impact factor: 5.934

6.  Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli.

Authors:  Jung-Joon Min; Hyun-Ju Kim; Jae Hyo Park; Sungmin Moon; Jae Ho Jeong; Yeoung-Jin Hong; Kyoung-Oh Cho; Jong Hee Nam; Nacksung Kim; Young-Kyu Park; Hee-Seung Bom; Joon Haeng Rhee; Hyon E Choy
Journal:  Mol Imaging Biol       Date:  2007-11-10       Impact factor: 3.488

7.  Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors.

Authors:  R M Ryan; J Green; P J Williams; S Tazzyman; S Hunt; J H Harmey; S C Kehoe; C E Lewis
Journal:  Gene Ther       Date:  2009-01-29       Impact factor: 5.250

Review 8.  Bacterial iron sources: from siderophores to hemophores.

Authors:  Cécile Wandersman; Philippe Delepelaire
Journal:  Annu Rev Microbiol       Date:  2004       Impact factor: 15.500

9.  Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration.

Authors:  N T Kimura; S Taniguchi; K Aoki; T Baba
Journal:  Cancer Res       Date:  1980-06       Impact factor: 12.701

10.  Bacteriolytic therapy can generate a potent immune response against experimental tumors.

Authors:  Nishant Agrawal; Chetan Bettegowda; Ian Cheong; Jean-Francois Geschwind; Charles G Drake; Edward L Hipkiss; Mitsuaki Tatsumi; Long H Dang; Luis A Diaz; Martin Pomper; Mohammad Abusedera; Richard L Wahl; Kenneth W Kinzler; Shibin Zhou; David L Huso; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-07       Impact factor: 11.205

View more
  7 in total

Review 1.  Salmonella-Mediated Cancer Therapy: Roles and Potential.

Authors:  Vu Hong Nguyen; Jung-Joon Min
Journal:  Nucl Med Mol Imaging       Date:  2016-06-01

2.  Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential.

Authors:  Dino Kocijancic; Sebastian Felgner; Michael Frahm; Ronja-Melinda Komoll; Aida Iljazovic; Vinay Pawar; Manfred Rohde; Ulrike Heise; Kurt Zimmermann; Florian Gunzer; Juliane Hammer; Katja Crull; Sara Leschner; Siegfried Weiss
Journal:  Oncotarget       Date:  2016-04-19

Review 3.  Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome.

Authors:  Sebastian Felgner; Vinay Pawar; Dino Kocijancic; Marc Erhardt; Siegfried Weiss
Journal:  Microb Biotechnol       Date:  2017-08-03       Impact factor: 5.813

4.  Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.

Authors:  Dino Kocijancic; Sebastian Felgner; Tim Schauer; Michael Frahm; Ulrike Heise; Kurt Zimmermann; Marc Erhardt; Siegfried Weiss
Journal:  Oncotarget       Date:  2017-07-25

Review 5.  Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy.

Authors:  Ze Mi; Zhi-Chao Feng; Cheng Li; Xiao Yang; Meng-Tian Ma; Peng-Fei Rong
Journal:  J Cancer       Date:  2019-08-20       Impact factor: 4.207

Review 6.  Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy.

Authors:  Elayne Irene Becerra-Báez; Sergio Enrique Meza-Toledo; Paola Muñoz-López; Luis Fernando Flores-Martínez; Karla Fraga-Pérez; Kevin Jorge Magaño-Bocanegra; Uriel Juárez-Hernández; Armando Alfredo Mateos-Chávez; Rosendo Luria-Pérez
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

Review 7.  Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica.

Authors:  Marco Antonio Hernández-Luna; Rosendo Luria-Pérez
Journal:  J Immunol Res       Date:  2018-09-13       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.